Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)
21.36
+0.09 (0.42%)
Mar 10, 2026, 11:54 AM CST
SHE:000766 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 20,557 | 15,174 | 19,272 | 5,093 | 4,591 | 3,151 | Upgrade
|
| Market Cap Growth | 39.93% | -21.26% | 278.37% | 10.95% | 45.71% | -50.15% | Upgrade
|
| Enterprise Value | 22,092 | 16,698 | 20,787 | 6,665 | 6,230 | 4,847 | Upgrade
|
| Last Close Price | 21.27 | 15.70 | 19.94 | 5.27 | 4.75 | 3.26 | Upgrade
|
| PE Ratio | 357.66 | 268.86 | 438.66 | 168.93 | 130.15 | - | Upgrade
|
| PS Ratio | 16.50 | 11.47 | 13.08 | 3.46 | 3.03 | 2.83 | Upgrade
|
| PB Ratio | 8.93 | 6.73 | 8.31 | 2.15 | 1.96 | 1.37 | Upgrade
|
| P/TBV Ratio | 9.68 | 7.34 | 9.12 | 2.40 | 2.22 | 1.56 | Upgrade
|
| P/FCF Ratio | 308.84 | 133.60 | 223.80 | 29.20 | 40.68 | 51.19 | Upgrade
|
| P/OCF Ratio | 168.29 | 93.24 | 170.88 | 25.70 | 33.19 | 39.04 | Upgrade
|
| EV/Sales Ratio | 17.73 | 12.63 | 14.11 | 4.53 | 4.11 | 4.36 | Upgrade
|
| EV/EBITDA Ratio | 104.57 | 81.53 | 105.79 | 34.61 | 34.10 | - | Upgrade
|
| EV/EBIT Ratio | 145.13 | 118.94 | 170.73 | 55.11 | 54.98 | - | Upgrade
|
| EV/FCF Ratio | 331.90 | 147.02 | 241.40 | 38.21 | 55.21 | 78.76 | Upgrade
|
| Debt / Equity Ratio | 0.81 | 0.80 | 0.73 | 0.76 | 0.79 | 0.91 | Upgrade
|
| Debt / EBITDA Ratio | 8.80 | 8.70 | 8.66 | 9.34 | 10.14 | - | Upgrade
|
| Debt / FCF Ratio | 27.92 | 15.87 | 19.77 | 10.31 | 16.42 | 34.15 | Upgrade
|
| Net Debt / Equity Ratio | 0.67 | 0.68 | 0.66 | 0.62 | 0.66 | 0.69 | Upgrade
|
| Net Debt / EBITDA Ratio | 7.35 | 7.46 | 7.76 | 7.59 | 8.49 | -5.72 | Upgrade
|
| Net Debt / FCF Ratio | 23.06 | 13.45 | 17.70 | 8.38 | 13.74 | 25.90 | Upgrade
|
| Asset Turnover | 0.27 | 0.29 | 0.32 | 0.32 | 0.32 | 0.23 | Upgrade
|
| Inventory Turnover | 0.86 | 0.88 | 1.02 | 0.92 | 0.85 | 0.55 | Upgrade
|
| Quick Ratio | 1.56 | 0.38 | 1.28 | 1.25 | 0.38 | 1.42 | Upgrade
|
| Current Ratio | 2.25 | 0.56 | 1.94 | 1.84 | 0.57 | 2.00 | Upgrade
|
| Return on Equity (ROE) | 2.46% | 2.45% | 1.85% | 1.24% | 1.46% | -14.51% | Upgrade
|
| Return on Assets (ROA) | 2.08% | 1.95% | 1.65% | 1.62% | 1.47% | -4.47% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.01% | 3.07% | 2.50% | 1.82% | 1.66% | -9.06% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.80% | 6.00% | 3.10% | 3.00% | 4.30% | -8.20% | Upgrade
|
| Earnings Yield | 0.28% | 0.37% | 0.23% | 0.59% | 0.77% | -11.41% | Upgrade
|
| FCF Yield | 0.32% | 0.75% | 0.45% | 3.42% | 2.46% | 1.95% | Upgrade
|
| Payout Ratio | 143.00% | 150.57% | 189.66% | 293.85% | 276.41% | - | Upgrade
|
| Buyback Yield / Dilution | -7.41% | -7.05% | 12.57% | -13.97% | 9.24% | -0.40% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.